Lobster hemolymph as a utility for treatment of mammalian tissue lesions
AssigneeRobert C. Bayer
InventorRobert C. Bayer
Life of this patent
Estimating the term…
Abstract
The invention is crustacean hemolymph as a utility for the pharmaceutical and/or cosmetic treatment of viral and other neoplastic or pre-neoplastic mammalian tissue lesions. The method comprises topically administering to mammalian tissue a formula that is made from lobster hemolymph—neat; or lobster hemolymph extracts; or lobster hemolyph in combination with certain carriers, binders; or as an adjuvant. The hemolymph may be from various species of lobster, Homarus americanus in particular.
Claims20
A method of prophylactic and/or cosmetic treatments of viral or pre-neoplastic skin lesions, comprising administering to mammalian epidermis a topical formula that comprises lobster hemolymph or an extract of lobster hemolymph comprising the hemolymph hemocyanins resulting in the diminishment, amelioration and/or elimination of said lesions, wherein the lobster hemolymph is extracted from one or more of Homarus americanus, Homarus gammarus, and Panulirus argus.
(canceled)
(canceled)
Dependencies are inferred from the claim text.